ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/01 | 2,422 | 2,447 | 2,415 | 2,424 | +8 | +0.3% | 55,700 |
2023/08/31 | 2,407 | 2,428 | 2,407 | 2,416 | -2 | -0.1% | 45,700 |
2023/08/30 | 2,410 | 2,420 | 2,400 | 2,418 | +8 | +0.3% | 36,400 |
2023/08/29 | 2,418 | 2,418 | 2,397 | 2,410 | +4 | +0.2% | 20,500 |
2023/08/28 | 2,399 | 2,410 | 2,393 | 2,406 | +27 | +1.1% | 21,400 |
2023/08/25 | 2,369 | 2,386 | 2,366 | 2,379 | +5 | +0.2% | 22,100 |
2023/08/24 | 2,360 | 2,382 | 2,360 | 2,374 | +7 | +0.3% | 21,400 |
2023/08/23 | 2,347 | 2,370 | 2,346 | 2,367 | +1 | ±0% | 20,900 |
2023/08/22 | 2,343 | 2,366 | 2,333 | 2,366 | +28 | +1.2% | 23,600 |
2023/08/21 | 2,353 | 2,370 | 2,338 | 2,338 | +1 | ±0% | 27,300 |
2023/08/18 | 2,315 | 2,358 | 2,312 | 2,337 | -3 | -0.1% | 56,400 |
2023/08/17 | 2,367 | 2,378 | 2,326 | 2,340 | -49 | -2.1% | 50,100 |
2023/08/16 | 2,389 | 2,398 | 2,375 | 2,389 | -24 | -1% | 35,800 |
2023/08/15 | 2,413 | 2,428 | 2,399 | 2,413 | -11 | -0.5% | 56,300 |
2023/08/14 | 2,452 | 2,471 | 2,422 | 2,424 | -17 | -0.7% | 32,400 |
2023/08/10 | 2,418 | 2,441 | 2,405 | 2,441 | +29 | +1.2% | 26,900 |
2023/08/09 | 2,400 | 2,416 | 2,380 | 2,412 | +17 | +0.7% | 37,500 |
2023/08/08 | 2,361 | 2,400 | 2,360 | 2,395 | +34 | +1.4% | 33,100 |
2023/08/07 | 2,333 | 2,361 | 2,325 | 2,361 | +32 | +1.4% | 37,600 |
2023/08/04 | 2,330 | 2,350 | 2,310 | 2,329 | -31 | -1.3% | 63,500 |
2023/08/03 | 2,375 | 2,377 | 2,350 | 2,360 | -14 | -0.6% | 90,300 |
2023/08/02 | 2,380 | 2,397 | 2,368 | 2,374 | -7 | -0.3% | 64,100 |
2023/08/01 | 2,349 | 2,381 | 2,339 | 2,381 | +54 | +2.3% | 53,700 |
2023/07/31 | 2,374 | 2,374 | 2,318 | 2,327 | +3 | +0.1% | 68,100 |
2023/07/28 | 2,312 | 2,333 | 2,305 | 2,324 | -19 | -0.8% | 110,100 |
2023/07/27 | 2,308 | 2,344 | 2,308 | 2,343 | +16 | +0.7% | 60,200 |
2023/07/26 | 2,324 | 2,331 | 2,310 | 2,327 | -13 | -0.6% | 63,800 |
2023/07/25 | 2,371 | 2,371 | 2,332 | 2,340 | -23 | -1% | 45,100 |
2023/07/24 | 2,349 | 2,364 | 2,340 | 2,363 | +34 | +1.5% | 38,500 |
2023/07/21 | 2,314 | 2,337 | 2,304 | 2,329 | ±0 | ±0% | 63,100 |
2023/07/20 | 2,350 | 2,355 | 2,325 | 2,329 | -17 | -0.7% | 30,700 |
2023/07/19 | 2,351 | 2,351 | 2,321 | 2,346 | +19 | +0.8% | 60,600 |
2023/07/18 | 2,300 | 2,329 | 2,300 | 2,327 | +27 | +1.2% | 27,700 |
2023/07/14 | 2,291 | 2,309 | 2,284 | 2,300 | +23 | +1% | 39,200 |
2023/07/13 | 2,264 | 2,285 | 2,263 | 2,277 | -4 | -0.2% | 36,300 |
2023/07/12 | 2,314 | 2,323 | 2,281 | 2,281 | -30 | -1.3% | 58,600 |
2023/07/11 | 2,346 | 2,358 | 2,305 | 2,311 | -35 | -1.5% | 52,800 |
2023/07/10 | 2,355 | 2,363 | 2,340 | 2,346 | -7 | -0.3% | 52,500 |
2023/07/07 | 2,390 | 2,390 | 2,349 | 2,353 | -25 | -1.1% | 58,500 |
2023/07/06 | 2,381 | 2,400 | 2,366 | 2,378 | -24 | -1% | 74,900 |
2023/07/05 | 2,400 | 2,424 | 2,400 | 2,402 | -25 | -1% | 39,400 |
2023/07/04 | 2,409 | 2,446 | 2,402 | 2,427 | -22 | -0.9% | 93,000 |
2023/07/03 | 2,456 | 2,481 | 2,430 | 2,449 | +6 | +0.2% | 36,800 |
2023/06/30 | 2,456 | 2,471 | 2,424 | 2,443 | -9 | -0.4% | 81,600 |
2023/06/29 | 2,487 | 2,510 | 2,442 | 2,452 | -29 | -1.2% | 57,800 |
2023/06/28 | 2,461 | 2,483 | 2,440 | 2,481 | +41 | +1.7% | 47,700 |
2023/06/27 | 2,427 | 2,454 | 2,409 | 2,440 | -26 | -1.1% | 65,100 |
2023/06/26 | 2,492 | 2,497 | 2,462 | 2,466 | -61 | -2.4% | 46,500 |
2023/06/23 | 2,550 | 2,550 | 2,510 | 2,527 | +3 | +0.1% | 97,400 |
2023/06/22 | 2,535 | 2,565 | 2,499 | 2,524 | -9 | -0.4% | 98,000 |
301~
350
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム